- C03AA01 bendroflumethiazide
- C03BA10 xipamide
- C03BA11 indapamide
- C03CA01 furosemide
- C03CA02 bumetanide
- C03CA04 torasemide
- C03DA01 spironolactone
- C03DA04 eplerenone
- C03DB01 amiloride
- C03DB02 triamterene
- C03EA01 hydrochlorothiazide and potassium-sparing agents
- C03EA07 cyclopenthiazide and potassium-sparing agents
- C03EB01 furosemide and potassium-sparing agents
- C03XA01 tolvaptan
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).